Cargando…

Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme

BACKGROUND: The incidence of invasive meningococcal disease due to serogroup C (MenC) decreased in Portugal since the introduction of the conjugate vaccine (MCC) in the free market in 2001 and in the National Immunisation Plan in 2006. Considering the potential waning of the antibody response report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonçalves, Paulo, Sáez-López, Emma, Carneiro, Sofia, Simões, Maria João
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049472/ https://www.ncbi.nlm.nih.gov/pubmed/33857245 http://dx.doi.org/10.1371/journal.pone.0250103

Ejemplares similares

1994. Development of a Meningococcal Serogroup B Serum Bactericidal Assay Using Fetal Bovine Serum
por: Kim, Han Wool, et al.
Publicado: (2018)

Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy
por: Neri, Arianna, et al.
Publicado: (2022)

01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)

Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
por: Gioia, C.A.C., et al.
Publicado: (2017)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
por: Martinelli, Domenico, et al.
Publicado: (2015)

4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents
por: Biolchi, Alessia, et al.
Publicado: (2020)

Serogroup Y Meningococcal Disease, Colombia
por: Agudelo, Clara Inés, et al.
Publicado: (2008)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016
por: Mentzer, Dirk, et al.
Publicado: (2018)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
por: Biolchi, Alessia, et al.
Publicado: (2019)

Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades
por: Gargaté, Maria João, et al.
Publicado: (2016)

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
por: Vesikari, Timo, et al.
Publicado: (2016)

Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B
por: Kleinschmidt, Annett, et al.
Publicado: (2021)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
por: Racloz, Vanessa N, et al.
Publicado: (2010)

Serogroup X in Meningococcal Disease, Western Kenya
por: Materu, Sadiki, et al.
Publicado: (2007)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017
por: Krone, Manuel, et al.
Publicado: (2019)

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
por: McNeil, Lisa K., et al.
Publicado: (2018)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Meningococcal serogroups and surveillance: a systematic review and survey
por: Peterson, Meagan E, et al.
Publicado: (2019)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Recent Progress in the Prevention of Serogroup B Meningococcal Disease
por: Feavers, Ian M., et al.
Publicado: (2017)

Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
por: Kassianos, George, et al.
Publicado: (2023)

Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
por: Topaz, Nadav, et al.
Publicado: (2020)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
por: Lingappa, Jairam R., et al.
Publicado: (2003)

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

Meningococcal serogroup B disease in Turkey: A guess or reality?
por: Bakir, Mustafa
Publicado: (2014)

Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccines
por: Russell, Joanne E., et al.
Publicado: (2008)

Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines
por: Sullivan, Christopher B., et al.
Publicado: (2015)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
por: Folaranmi, Temitope, et al.
Publicado: (2015)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_48a05ffju9q6ii87alj2j1h4mo